GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The peptides that are under the GLP-1 class that everyone touts as the weight loss miracle are not new. They've been around ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

The GLP-1 RA cohort had significantly lower odds of developing early-onset colorectal cancer (0.4 vs 0.7%) vs the no GLP-1 RA cohort. HealthDay News — Glucagon-like peptide-1 receptor agonists ...

Novo Nordisk is investing further in obesity and metabolic disease, signing a deal to use Ascendis Pharma’s delivery technology to advance a long-acting GLP-1 drug as well as develop products in ...

The new menu was made specifically for people who take GLP-1 drugs like Ozempic and Wegovy. According to Smoothie King, the smoothies on the GLP-1 Support Menu all have at least 20 grams of ...

A study was conducted to examine the effect of GLP-1 receptor agonists on clinical outcomes in patients receiving SGLT2 inhibitors. The effects of glucagon-like peptide-1 (GLP-1) receptor agonists on ...

Background: GLP-1 RA use has skyrocketed in the U.S., expanding from use as an agent for diabetes to new indications including weight loss. Due to concerns for increased risk of pulmonary aspiration ...